<!DOCTYPE html>
<html lang="zh-TW">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>ATLS Chapter 6 - Circulation Assessment and Volume Resuscitation 考前重點複習筆記</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: #333;
            background-color: #f5f7fa;
            position: relative;
        }

        /* 進度條 */
        #progress-bar {
            position: fixed;
            top: 0;
            left: 0;
            width: 0%;
            height: 4px;
            background: linear-gradient(90deg, #007bff, #00c853);
            z-index: 1000;
            transition: width 0.3s ease;
        }

        /* 主標題 */
        .main-header {
            background: linear-gradient(135deg, #1e3c72 0%, #2a5298 100%);
            color: white;
            padding: 30px 20px;
            text-align: center;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
        }

        .main-header h1 {
            font-size: 2em;
            margin-bottom: 10px;
        }

        .main-header p {
            font-size: 1.1em;
            opacity: 0.9;
        }

        /* 導覽容器 */
        .nav-container {
            background: white;
            padding: 20px;
            box-shadow: 0 2px 5px rgba(0,0,0,0.1);
            position: sticky;
            top: 0;
            z-index: 100;
        }

        /* 下拉式選單 */
        .dropdown-nav {
            display: flex;
            flex-wrap: wrap;
            gap: 10px;
            margin-bottom: 20px;
            justify-content: center;
        }

        .dropdown {
            position: relative;
            display: inline-block;
        }

        .dropdown-button {
            background: #e3f2fd;
            border: 1px solid #1976d2;
            padding: 8px 16px;
            cursor: pointer;
            border-radius: 5px;
            font-size: 0.9em;
            display: flex;
            align-items: center;
            gap: 5px;
            transition: all 0.3s ease;
        }

        .dropdown-button:hover {
            background: #1976d2;
            color: white;
        }

        .dropdown-content {
            display: none;
            position: absolute;
            background: white;
            min-width: 250px;
            box-shadow: 0 8px 16px rgba(0,0,0,0.2);
            border-radius: 5px;
            z-index: 1;
            max-height: 400px;
            overflow-y: auto;
        }

        .dropdown-content a {
            color: black;
            padding: 12px 16px;
            text-decoration: none;
            display: block;
            transition: background 0.3s ease;
        }

        .dropdown-content a:hover {
            background: #f1f1f1;
        }

        .dropdown:hover .dropdown-content {
            display: block;
        }

        /* 分頁標籤 */
        .tabs {
            display: flex;
            justify-content: center;
            flex-wrap: wrap;
            gap: 5px;
        }

        .tab-button {
            background: #f0f0f0;
            border: none;
            padding: 10px 20px;
            cursor: pointer;
            border-radius: 5px 5px 0 0;
            font-size: 0.95em;
            transition: all 0.3s ease;
            display: flex;
            align-items: center;
            gap: 5px;
        }

        .tab-button.active {
            background: #2196f3;
            color: white;
        }

        .tab-button:hover {
            background: #1976d2;
            color: white;
        }

        /* 內容區域 */
        .content {
            max-width: 1200px;
            margin: 20px auto;
            padding: 0 20px;
        }

        .tab-content {
            display: none;
            background: white;
            padding: 30px;
            border-radius: 10px;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
            animation: fadeIn 0.5s ease;
        }

        .tab-content.active {
            display: block;
        }

        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(10px); }
            to { opacity: 1; transform: translateY(0); }
        }

        /* 資訊區塊 */
        .info-box {
            padding: 20px;
            margin: 20px 0;
            border-radius: 8px;
            border-left: 5px solid;
            box-shadow: 0 2px 5px rgba(0,0,0,0.1);
        }

        .concept-box {
            background: #e3f2fd;
            border-color: #2196f3;
        }

        .warning-box {
            background: #fff3cd;
            border-color: #ffc107;
        }

        .danger-box {
            background: #f8d7da;
            border-color: #dc3545;
        }

        .dosage-box {
            background: #e7e3ff;
            border-color: #6f42c1;
        }

        .physiology-box {
            background: #d4edda;
            border-color: #28a745;
        }

        .chart-box {
            background: #ffe5d0;
            border-color: #fd7e14;
        }

        /* 收合式問答 */
        .qa-item {
            margin: 15px 0;
            border: 1px solid #ddd;
            border-radius: 8px;
            overflow: hidden;
        }

        .qa-question {
            padding: 15px;
            background: #f8f9fa;
            cursor: pointer;
            display: flex;
            justify-content: space-between;
            align-items: center;
            transition: background 0.3s ease;
        }

        .qa-question:hover {
            background: #e9ecef;
        }

        .qa-answer {
            padding: 0 15px;
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.3s ease, padding 0.3s ease;
            background: white;
        }

        .qa-answer.open {
            padding: 15px;
            max-height: 500px;
        }

        .qa-toggle {
            font-size: 1.2em;
            transition: transform 0.3s ease;
        }

        .qa-toggle.open {
            transform: rotate(180deg);
        }

        /* 表格樣式 */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            font-size: 0.9em;
        }

        th, td {
            padding: 12px;
            text-align: left;
            border: 1px solid #ddd;
        }

        th {
            background: #f8f9fa;
            font-weight: bold;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }
        
        /* START: Added styles for hemorrhage severity table */
        #hemorrhage-severity-table {
            border-radius: 8px;
            overflow: hidden; /* This clips the child elements to the parent's border-radius */
            border-collapse: separate; /* separate is needed for border-radius to work on tables */
            border-spacing: 0;
            border: 1px solid #ddd;
        }

        /* Override generic even-row styling for this specific table */
        #hemorrhage-severity-table tr:nth-child(even) {
            background-color: transparent;
        }

        #hemorrhage-severity-table th, 
        #hemorrhage-severity-table td {
             border:none; /* Remove default borders */
        }
        
        /* Column Background Colors using nth-child selectors */
        #hemorrhage-severity-table td:nth-child(2) { background-color: #fef9c3; } /* MINOR - Yellow */
        #hemorrhage-severity-table td:nth-child(3) { background-color: #fed7aa; } /* MODERATE - Orange */
        #hemorrhage-severity-table td:nth-child(4) { background-color: #fca5a5; } /* MAJOR - Red */
        #hemorrhage-severity-table td:nth-child(5) { background-color: #f87171; } /* MASSIVE - Darker Red */
        
        /* Make text white on the darkest column for better readability */
        #hemorrhage-severity-table td:nth-child(5) {
             color: white;
        }

        /* Header specific styles */
        #hemorrhage-severity-table thead th {
            background-color: #1e3c72; /* Dark blue to match main header */
            color: white;
            text-align: center;
        }
        
        /* Parameter column (first column) specific style */
        #hemorrhage-severity-table tbody td:first-child {
            background-color: #f8f9fa; /* Light grey */
            font-weight: bold;
        }
        /* END: Added styles for hemorrhage severity table */

        /* START: Styles for improved bleeding locations diagram */
        #bleeding-locations-diagram .diagram-container {
            display: grid;
            grid-template-columns: 1fr 1fr 1fr;
            grid-template-rows: auto auto auto;
            grid-template-areas:
                "external . thoracic"
                "central central central"
                "longbone retro peritoneal";
            gap: 15px;
            padding: 20px;
            position: relative;
            align-items: stretch;
        }
        #bleeding-locations-diagram .central-hub {
            grid-area: central;
            background-color: #dc3545;
            color: white;
            border-radius: 10px;
            padding: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            text-align: center;
            font-weight: bold;
            font-size: 1.2em;
            box-shadow: 0 4px 10px rgba(0,0,0,0.2);
            z-index: 10;
            margin: 10px 0;
        }
        #bleeding-locations-diagram .location-box {
            border: 2px solid #ddd;
            border-radius: 8px;
            padding: 15px;
            background: #fdfdfd;
            display: flex;
            flex-direction: column;
        }
        #bleeding-locations-diagram .location-box h5 {
            color: #1e3c72;
            margin-top: 0;
            margin-bottom: 10px;
            border-bottom: 1px solid #eee;
            padding-bottom: 5px;
        }
        #bleeding-locations-diagram .location-box ul {
            margin-left: 15px;
            padding-left: 0;
            font-size: 0.9em;
            flex-grow: 1;
        }
        #bleeding-locations-diagram .thoracic-cavity { grid-area: thoracic; }
        #bleeding-locations-diagram .peritoneal-cavity { grid-area: peritoneal; }
        #bleeding-locations-diagram .retroperitoneal-space { grid-area: retro; }
        #bleeding-locations-diagram .long-bone { grid-area: longbone; }
        #bleeding-locations-diagram .external-hemorrhage { grid-area: external; }
        
        #bleeding-locations-diagram .diagram-footnote {
            margin-top: 20px;
            text-align: center;
        }

        /* Responsive layout for the diagram */
        @media (max-width: 992px) {
            #bleeding-locations-diagram .diagram-container {
                grid-template-columns: 1fr 1fr;
                grid-template-areas:
                    "external thoracic"
                    "central central"
                    "longbone peritoneal"
                    "retro retro";
            }
        }
        @media (max-width: 768px) {
            #bleeding-locations-diagram .diagram-container {
                display: flex;
                flex-direction: column;
            }
        }
        /* END: Styles for improved bleeding locations diagram */

        /* 功能按鈕 */
        #download-pdf {
            position: fixed;
            top: 20px;
            right: 20px;
            background: #28a745;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 5px;
            cursor: pointer;
            font-size: 16px;
            display: flex;
            align-items: center;
            gap: 5px;
            box-shadow: 0 2px 5px rgba(0,0,0,0.2);
            z-index: 999;
            transition: all 0.3s ease;
        }

        #download-pdf:hover {
            background: #218838;
            transform: translateY(-2px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.3);
        }

        #back-to-top {
            position: fixed;
            bottom: 20px;
            right: 20px;
            background: #007bff;
            color: white;
            border: none;
            width: 50px;
            height: 50px;
            border-radius: 50%;
            cursor: pointer;
            font-size: 20px;
            display: none;
            align-items: center;
            justify-content: center;
            box-shadow: 0 2px 10px rgba(0,0,0,0.2);
            z-index: 999;
            transition: all 0.3s ease;
        }

        #back-to-top:hover {
            background: #0056b3;
            transform: translateY(-5px);
            box-shadow: 0 4px 15px rgba(0,0,0,0.3);
        }

        /* 版權聲明 */
        .copyright-notice {
            background: #f8d7da;
            border: 1px solid #f5c6cb;
            border-radius: 8px;
            padding: 20px;
            margin: 20px 0;
            color: #721c24;
        }

        .copyright-notice h4 {
            margin-bottom: 10px;
            color: #721c24;
        }

        /* 響應式設計 */
        @media (max-width: 768px) {
            .main-header h1 {
                font-size: 1.5em;
            }

            .dropdown-nav {
                flex-direction: column;
            }

            .tabs {
                flex-direction: column;
            }

            .tab-button {
                width: 100%;
                justify-content: center;
            }

            #download-pdf {
                top: auto;
                bottom: 80px;
            }

            table {
                font-size: 0.8em;
            }

            th, td {
                padding: 8px;
            }
        }

        /* 列印樣式 */
        @media print {
            body {
                background: white;
            }

            #progress-bar,
            .nav-container,
            #download-pdf,
            #back-to-top {
                display: none !important;
            }

            .tab-content {
                display: block !important;
                page-break-after: always;
                box-shadow: none;
                margin-bottom: 50px;
            }

            .qa-answer {
                max-height: none !important;
                padding: 15px !important;
            }

            .info-box {
                break-inside: avoid;
            }

            .copyright-notice {
                break-inside: avoid;
            }
        }

        /* 強調文字 */
        .highlight {
            background-color: #ffeb3b;
            padding: 2px 4px;
            border-radius: 3px;
        }

        /* 圖標樣式 */
        .icon {
            margin-right: 5px;
        }

        /* 清單樣式 */
        ul {
            margin-left: 20px;
            margin-top: 10px;
            margin-bottom: 10px;
        }

        ol {
            margin-left: 20px;
            margin-top: 10px;
            margin-bottom: 10px;
        }

        li {
            margin-bottom: 5px;
        }
    </style>
</head>
<body>
    <div id="progress-bar"></div>

    <div class="main-header">
        <h1>📚 ATLS Chapter 6 - 循環評估與容積復甦 考前重點複習筆記</h1>
        <p>🏥 Circulation Assessment and Volume Resuscitation 互動式學習系統</p>
    </div>

    <button id="download-pdf" onclick="downloadPDF()">
        📥 下載PDF
    </button>

    <button id="back-to-top" onclick="scrollToTop()">
        ⬆
    </button>

    <div class="nav-container">
        <div class="dropdown-nav">
            <div class="dropdown">
                <button class="dropdown-button">📋 一般性重點筆記 ▼</button>
                <div class="dropdown-content">
                    <a href="#general-core">核心概念摘要</a>
                    <a href="#general-shock">休克定義與分類</a>
                    <a href="#general-identification">早期辨識指標</a>
                    <a href="#general-bleeding">五大失血處</a>
                    <a href="#general-fast">FAST超音波評估</a>
                    <a href="#general-strategy">出血控制與輸血策略</a>
                    <a href="#general-qa">主動回憶問題庫</a>
                </div>
            </div>
            
            <div class="dropdown">
                <button class="dropdown-button">⚠️ 進階觀念與應考陷阱 ▼</button>
                <div class="dropdown-content">
                    <a href="#advanced-concepts">潛藏高階觀念</a>
                    <a href="#advanced-traps">模擬考官陷阱題</a>
                    <a href="#advanced-physiology">關鍵生理病理解析</a>
                    <a href="#advanced-qa">進階主動回憶問題</a>
                </div>
            </div>
            
            <div class="dropdown">
                <button class="dropdown-button">🚨 臨床現場實用資訊 ▼</button>
                <div class="dropdown-content">
                    <a href="#clinical-emergency">緊急狀況快速應變</a>
                    <a href="#clinical-dosing">臨床常用劑量速查</a>
                    <a href="#clinical-anticoagulation-reversal">抗凝藥物逆轉策略</a>
                    <a href="#clinical-assessment">關鍵評估與判讀</a>
                    <a href="#clinical-procedures">實務操作核心提示</a>
                </div>
            </div>
            
            <div class="dropdown">
                <button class="dropdown-button">📊 重要圖表整理 ▼</button>
                <div class="dropdown-content">
                    <a href="#chart-hemorrhage">失血嚴重度分級表</a>
                    <a href="#chart-bleeding">失血位置示意圖</a>
                    <a href="#chart-pelvic">骨盆容積變化圖</a>
                    <a href="#chart-flow">導管流速比較表</a>
                </div>
            </div>
            
            <div class="dropdown">
                <button class="dropdown-button">📌 其他重要重點 ▼</button>
                <div class="dropdown-content">
                    <a href="#other-nonhemorrhagic">非出血性休克分類</a>
                    <a href="#other-population">不同族群復甦差異</a>
                    <a href="#other-tca">創傷性心搏停止</a>
                </div>
            </div>
        </div>

        <div class="tabs">
            <button class="tab-button active" onclick="showTab('general')">
                📋 一般性重點筆記
            </button>
            <button class="tab-button" onclick="showTab('advanced')">
                ⚠️ 進階觀念與應考陷阱
            </button>
            <button class="tab-button" onclick="showTab('clinical')">
                🚨 臨床現場實用資訊
            </button>
            <button class="tab-button" onclick="showTab('charts')">
                📊 重要圖表整理
            </button>
            <button class="tab-button" onclick="showTab('others')">
                📌 其他重要重點
            </button>
        </div>
    </div>

    <div class="content">
        <div class="copyright-notice">
            <h4>⚖️ 版權聲明與使用限制</h4>
            <p>本網頁內容使用GAI生成</p>
            <p>本網頁為自學用途之中文編譯版本，非官方授權翻譯。</p>
            <ul>
                <li>原文版權屬於American College of Surgeons Committee on Trauma</li>
                <li>本網頁教材旨在促進醫學教育發展，僅供學習者參考使用，嚴禁任何商業用途</li>
                <li>讀者若需完整理解原文，建議參閱原始英文版本</li>
            </ul>
        </div>

        <div id="general" class="tab-content active">
            <h2>📋 一般性重點筆記</h2>
            
            <div class="concept-box">
                <h3 id="general-core">🎯 核心概念摘要</h3>
                <ul>
                    <li><strong>休克分類</strong>：Hemorrhagic vs. Obstructive (Tension Pneumothorax, Cardiac Tamponade) / Cardiogenic (Blunt Cardiac Injury) / Distributive (Neurogenic, Septic)</li>
                    <li><strong>早期識別</strong>：Tachycardia + 皮膚冷濕即視為休克；Shock Index ≥ 0.8 提示需輸血</li>
                    <li><strong>關鍵生理指標</strong>：Lactate、Base Deficit、尿量 (<0.5 mL/kg/hr) 監控復甦成效</li>
                    <li><strong>處置優先序</strong>：止血→大口徑 IV/IO→血品 1:1:1→Permissive Hypotension→TXA→持續再評估 (Responder 分類)</li>
                </ul>
            </div>

            <h3 id="general-shock">💉 休克定義與分類</h3>
            <div class="danger-box">
                <p><strong>🚨 休克定義</strong>：器官供氧不足的警報燈 - 血液載氧量 ↓ → 細胞能量製造停擺 → 器官失能</p>
                <p><strong>創傷病人最常見</strong>：<span class="highlight">Hemorrhagic Shock</span></p>
                <p><strong>非出血性休克</strong>：記憶口訣「<strong>O-C-D</strong>」</p>
                <ul>
                    <li>🚫 <strong>O</strong>bstructive（阻塞性）</li>
                    <li>❤️ <strong>C</strong>ardiogenic（心因性）</li>
                    <li>🌡️ <strong>D</strong>istributive（分布性）</li>
                </ul>
            </div>

            <h3 id="general-identification">🔍 早期辨識指標</h3>
            <div class="warning-box">
                <p><strong>最早可量測徵象</strong>：<span class="highlight">Tachycardia</span></p>
                <p><strong>Shock Index (SI)</strong> = HR / SBP</p>
                <ul>
                    <li>正常值：≤ 0.7</li>
                    <li>警戒值：≥ 0.8（需考慮輸血）</li>
                    <li>危險值：≥ 1.0（高死亡率相關）</li>
                </ul>
                <p>💡 記憶口訣：「<strong>HR over BP, if > One call 119</strong>」</p>
            </div>

            <h3 id="general-bleeding">🩸 五大失血處</h3>
            <div class="physiology-box">
                <p><strong>記憶口訣</strong>：「<strong>One on the Floor & Four More</strong>」</p>
                <ol>
                    <li>🫁 胸腔（Chest）</li>
                    <li>🏥 腹腔（Abdomen）</li>
                    <li>🦴 骨盆/後腹腔（Pelvis/Retroperitoneum）</li>
                    <li>🦵 長骨/軟組織（Long bones/Soft tissue）</li>
                    <li>🩸 外部出血（External - "on the floor"）</li>
                </ol>
                <p>💡 故事記憶法：「地板上一灘血 (floor) → 抬頭看胸、腹、骨盆、長骨 (four)」</p>
            </div>

            <div class="concept-box">
                <h3 id="general-fast">🔍 FAST 超音波評估 (Focused Assessment with Sonography for Trauma)</h3>
                <p><strong>定義</strong>：一種快速、非侵入性的床邊超音波檢查，用於快速偵測創傷病患是否有腹腔內出血 (hemoperitoneum) 或心包填塞 (hemopericardium)。</p>
                <h4>四大標準探查位置 (Standard Views):</h4>
                <ol>
                    <li><strong>心包膜下 (Subxiphoid)</strong>：評估心包膜是否積液。</li>
                    <li><strong>右上腹 (Right Upper Quadrant - RUQ)</strong>：探查肝腎交界的 Morrison's Pouch。</li>
                    <li><strong>左上腹 (Left Upper Quadrant - LUQ)</strong>：探查脾腎交界 (splenorenal recess)。</li>
                    <li><strong>骨盆腔 (Pelvic)</strong>：探查膀胱後方的陷凹 (pouch of Douglas)。</li>
                </ol>
                <h4>eFAST (延伸版):</h4>
                <p>eFAST (Extended FAST) 額外增加了<strong>雙側胸腔前側</strong>的探查，用以評估是否存在氣胸 (pneumothorax) 或血胸 (hemothorax)。</p>
                <h4>優點與侷限:</h4>
                <ul>
                    <li><strong>優點</strong>: 非侵入性、可重複檢查、能同時掃描胸腹部。</li>
                    <li><strong>侷限</strong>: 早期少量出血可能不易偵測、結果高度依賴操作者經驗。</li>
                </ul>
            </div>

            <h3 id="general-strategy">🩺 出血控制與輸血策略</h3>
            <div class="dosage-box">
                <h4>立即處置流程</h4>
                <ol>
                    <li>🩹 立即止血（直接加壓/止血帶）</li>
                    <li>💉 建立大口徑靜脈通路（16G以上 x 2）</li>
                    <li>🩸 啟動輸血：<strong>1:1:1</strong>（PRBC:FFP:Platelet）或低滴度O型全血</li>
                    <li>📉 Permissive Hypotension：
                        <ul>
                            <li>刺穿傷：SBP ≈ 90 mmHg</li>
                            <li>頭/脊髓傷：SBP ≥ 110 mmHg</li>
                        </ul>
                        <p>💡 記憶口訣：「<strong>九十止血，百一護腦</strong>」</p>
                    </li>
                    <li>💊 TXA給藥（3小時內）：1g IV 10分鐘 + 1g/8hr 或 單次2g</li>
                </ol>
            </div>

            <h3 id="general-qa">❓ 主動回憶問題庫</h3>
            <div class="qa-container">
                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>Q1: 創傷休克最常見病因？</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>答案</strong>：Hemorrhagic Shock（出血性休克）</p>
                    </div>
                </div>

                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>Q2: Shock Index 正常值與危險臨界？</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>答案</strong>：≤0.7 正常；≥1 高死亡率</p>
                    </div>
                </div>

                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>Q3: 非出血性休克三大類？</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>答案</strong>：Obstructive, Cardiogenic, Distributive (O-C-D)</p>
                    </div>
                </div>

                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>Q4: 五大失血位置口訣？</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>答案</strong>："Four and the Floor"（胸、腹、骨盆/後腹腔、長骨/軟組織 + 外部出血）</p>
                    </div>
                </div>

                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>Q5: Permissive Hypotension 對 SBP 目標？</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>答案</strong>：90 mmHg（刺穿傷）；110 mmHg（頭/脊傷）</p>
                    </div>
                </div>

                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>Q6: Responder 與 Non-responder 最大差別？</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>答案</strong>：是否在輸液後維持 hemodynamics</p>
                    </div>
                </div>

                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>Q7: Pelvic Binder 置放位置？</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>答案</strong>：包住 Greater Trochanters（大轉子）</p>
                    </div>
                </div>

                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>Q8: TXA 給藥黃金時間？</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>答案</strong>：受傷 3 hr 內</p>
                    </div>
                </div>

                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>Q9: 早期休克最敏感生命徵象？</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>答案</strong>：Tachycardia（心搏過速）</p>
                    </div>
                </div>

                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>Q10: 休克時最可靠之代謝指標？</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>答案</strong>：Lactate ↑ 或 Base Deficit ↓</p>
                    </div>
                </div>
            </div>
        </div>

        <div id="advanced" class="tab-content">
            <h2>⚠️ 進階觀念與應考陷阱</h2>
            
            <h3 id="advanced-concepts">🎯 潛藏高階觀念與易忽略細節</h3>
            
            <div class="danger-box">
                <h4>🚨 特殊族群的假陰性休克</h4>
                <p><strong>為什麼重要？</strong>高齡β阻斷、孕婦血容量↑、運動員靜息HR↓，皆會「遮蔽」心跳與血壓變化。</p>
                <p><strong>隱藏陷阱</strong>：只靠 HR / BP 易漏診；以乳酸、Base Deficit及皮膚灌流評估</p>
                <p>💡 記憶口訣：「<strong>BAPPA</strong>」- Beta-blocker、Athlete、Pregnancy、Pacemaker、Age > 65</p>
            </div>

            <div class="warning-box">
                <h4>⏰ TXA 時效 & 劑量差異</h4>
                <p><strong>關鍵時限</strong>：>3 hr 給藥反增栓塞風險</p>
                <p><strong>劑量選擇</strong>：可用「1 g＋1 g/8 hr」或單次 2 g</p>
                <p><strong>考官常問</strong>：「到院 4 hr還能否給？」</p>
                <p>✅ <strong>正確答案</strong>：除非確證 hyperfibrinolysis（TEG/ROTEM），否則停用</p>
                <p>💡 記憶口訣：「<strong>三小時，三不給</strong>」- 超3hr、無超纖、無外傷出血 ⇒ 停用</p>
            </div>

            <div class="dosage-box">
                <h4>💊 抗凝逆轉策略</h4>
                <table>
                    <tr>
                        <th>抗凝藥物</th>
                        <th>逆轉劑</th>
                        <th>劑量/注意事項</th>
                    </tr>
                    <tr>
                        <td>Warfarin</td>
                        <td>Vit K + 4-factor PCC</td>
                        <td>5-10 mg IV + PCC</td>
                    </tr>
                    <tr>
                        <td>Rivaroxaban/Apixaban</td>
                        <td>Andexanet α</td>
                        <td>依最後服藥時間分高低方案</td>
                    </tr>
                    <tr>
                        <td>Dabigatran</td>
                        <td>Idarucizumab</td>
                        <td>5 g (2 × 2.5 g)</td>
                    </tr>
                    <tr>
                        <td>LMWH</td>
                        <td>Protamine</td>
                        <td><8hr: 1mg/1mg<br>8-12hr: 0.5mg/1mg<br>>12hr: 不給</td>
                    </tr>
                </table>
                <p>⚠️ <strong>易錯陷阱</strong>：易把 dabigatran 當 Xa 抑制劑；實際為直接 thrombin inhibitor</p>
            </div>

            <h3 id="advanced-traps">🎭 模擬考官出題視角</h3>
            
            <div class="qa-container">
                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>🏃 運動員休克指標題：25歲馬拉松選手，失血1.5L，HR 90, BP 100/60，Shock Index 0.9</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>陷阱</strong>：Shock Index 0.9 被視作「正常」</p>
                        <p><strong>鑑別</strong>：運動員靜息 HR 50 → 失血 2 L 仍僅 HR 100，SI = 1.0 = 危險</p>
                        <p>✅ <strong>正確處置</strong>：立即輸血，不要被「正常」數值誤導</p>
                    </div>
                </div>

                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>🤰 孕婦 SBP 90 mmHg：28週孕婦車禍，SBP 90，是否屬於 permissive hypotension？</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>陷阱</strong>：認為屬於 permissive hypotension</p>
                        <p><strong>真相</strong>：第三孕期生理性低壓但子宮壓 IVC → 先左移子宮再評估</p>
                        <p>✅ <strong>正確處置</strong>：左側傾斜15°或手動左移子宮，再評估血壓</p>
                    </div>
                </div>

                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>⏱️ TXA超時給藥：刀傷病人到院已4小時，是否給TXA？</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>陷阱</strong>：依靠 CRASH-2 數據而忽略時效上限</p>
                        <p><strong>重點</strong>：超時僅在 TEG/Ly30>3% 等明確 hyperfibrinolysis 才考慮</p>
                        <p>✅ <strong>正確答案</strong>：不給，除非有實驗室證據支持超纖溶</p>
                    </div>
                </div>

                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>👶 小兒血壓正常即安全？5歲男童，車禍，HR 140, BP 90/60</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>陷阱</strong>：忽視兒童後期崩潰特性</p>
                        <p><strong>警示</strong>：觀察心率與膚色；一旦出現 Bradycardia → 末期休克</p>
                        <p>✅ <strong>正確評估</strong>：HR 140已是顯著心搏過速，需立即輸液/輸血</p>
                    </div>
                </div>
            </div>

            <h3 id="advanced-physiology">🧬 關鍵生理／病理學解析</h3>
            
            <div class="physiology-box">
                <h4>💊 β-Blocker Masking</h4>
                <p>HR 受 β1 抑制，周邊血管仍收縮 → 皮膚涼、乳酸升高成最早警訊</p>
            </div>

            <div class="physiology-box">
                <h4>⏰ TXA 時窗生理學</h4>
                <p>創傷後 3 hr 內膠原與纖溶失衡最劇；之後纖溶活性下降，額外抑制 → 微血栓</p>
            </div>

            <div class="physiology-box">
                <h4>💉 Vasopressor 加劇缺氧</h4>
                <p>收縮前微血管造成 Shunting，氧氣無法交換；短暫提壓可保腦灌流，但持續使用將惡化代謝酸中毒</p>
            </div>

            <div class="physiology-box">
                <h4>🔬 Poiseuille 定律</h4>
                <p>Flow ∝ r⁴ / L</p>
                <p>半徑 2→3 mm，流速增加 (3⁴ / 2⁴) ≈ 5 倍</p>
                <p>💡 記憶口訣：「<strong>短粗飆、水快流（r⁴/L）</strong>」</p>
            </div>

            <h3 id="advanced-qa">🧠 進階主動回憶問題庫</h3>
            
            <div class="qa-container">
                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>24 週孕婦到院 SBP 90，首要措施？</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>答案</strong>：左側傾或手動左移子宮</p>
                    </div>
                </div>

                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>服用 Rivaroxaban 6 hr前受傷大出血首選逆轉藥？</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>答案</strong>：Andexanet α (高劑量方案)</p>
                    </div>
                </div>

                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>何時可考慮停止鈍傷 CPR？</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>答案</strong>：無生命徵象且 CPR >10 min</p>
                    </div>
                </div>

                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>18 G×45 cm CVC vs 16 G×4 cm IV，何者流速較快？</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>答案</strong>：16 G 周邊 IV (半徑大且短)</p>
                    </div>
                </div>

                <div class="qa-item">
                    <div class="qa-question" onclick="toggleAnswer(this)">
                        <span>神經原性休克 MAP 目標？</span>
                        <span class="qa-toggle">▼</span>
                    </div>
                    <div class="qa-answer">
                        <p><strong>答案</strong>：≥85 mmHg；需早期 Norepinephrine</p>
                    </div>
                </div>
            </div>
        </div>

        <div id="clinical" class="tab-content">
            <h2>🚨 臨床現場實用資訊</h2>
            
            <h3 id="clinical-emergency">🚑 緊急狀況快速應變</h3>
            
            <div class="danger-box">
                <h4>🩸 大量出血 + 低血壓</h4>
                <p><strong>核心判斷</strong>：SBP < 90 mmHg 或 Shock Index ≥ 1</p>
                <p><strong>立即SOP</strong>：</p>
                <ol>
                    <li>壓迫／止血帶或包扎 «floor»</li>
                    <li>同時啟動 <strong>MTP</strong>：快速輸注 O PRBC + AB FFP（1:1:1）</li>
                    <li>若可用，優先「低滴度 O 全血」</li>
                </ol>
            </div>

            <div class="warning-box">
                <h4>🦴 骨盆骨折失血</h4>
                <p><strong>核心判斷</strong>：機轉 + 下腹痛 + 下肢外旋</p>
                <p><strong>立即處置</strong>：立即置放 <strong>Pelvic Binder</strong> 於 <em>greater trochanters</em>（非髂前上棘），並內收雙腿固定外旋</p>
            </div>

            <div class="dosage-box">
                <h4>🤰 懷孕病患低血壓</h4>
                <p><strong>核心判斷</strong>：妊娠 20 週後 + 臥姿 SBP ↓</p>
                <p><strong>立即處置</strong>：先「手動左移子宮」或右側臥 15° 釋放 IVC，再評估輸血需求</p>
            </div>

            <h3 id="clinical-dosing">💊 臨床常用劑量速查</h3>
            <table>
                <tr>
                    <th>藥物／製劑</th>
                    <th>適應症</th>
                    <th>臨床常用劑量</th>
                    <th>特別提示</th>
                </tr>
                <tr>
                    <td><strong>初始輸液量</strong></td>
                    <td>無血品暫替</td>
                    <td>成人晶體液 250-500 mL；兒童 10 mL/kg</td>
                    <td>預熱至 39 °C 以防低溫</td>
                </tr>
                 <tr>
                    <td><strong>TXA</strong></td>
                    <td>大量出血；到院 < 3 hr</td>
                    <td>1 g IV push 10 min → 再 1 g/8 hr <em>或</em> 單次 2 g</td>
                    <td>>3 hr 若無 TEG/ROTEM「超纖」則不再給</td>
                </tr>
            </table>

            <div class="dosage-box">
                <h3 id="clinical-anticoagulation-reversal">💊 抗凝藥物逆轉策略 (Table 6-7)</h3>
                <table>
                     <thead>
                        <tr>
                            <th>抗凝/抗血小板藥物</th>
                            <th>治療選項</th>
                            <th>註解/注意事項</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><b>抗血小板藥物</b><br>e.g., aspirin, clopidogrel (Plavix®), ticagrelor (Brilinta®), prasugrel (Effient®), dipyridamole, abciximab (Reopro®), eptifibatide (Integrilin®), tirofiban (Aggrastat®)</td>
                            <td>• 判定為輕微或嚴重出血<br>• <b>輕微:</b> Desmopressin (DDAVP) 0.3 mcg/kg 單次<br>• <b>嚴重:</b> 血小板輸注 (用於危及生命之出血或計畫中的神經外科手術)<br>• DDAVP 0.4 mg/kg<br>• TXA 可能有益<br>• EACA: 4g loading, 之後 1g/hr, 最多4小時</td>
                            <td>• 常規輸注血小板在某研究中顯示預後較差<br>• DDAVP 有理論依據，但療效數據有限<br>• 殘餘的抗血小板藥物可能抑制輸注的血小板功能<br>• EACA 可能增加DVT風險</td>
                        </tr>
                        <tr>
                            <td><b>維他命K拮抗劑</b><br>e.g., warfarin (Coumadin®)</td>
                            <td>• 維他命K 5-10 mg IV<br>• <b>加上</b> 四因子PCC<br>• <b>或</b> FFP 10-15 mL/kg</td>
                            <td>• 將INR正常化<br>• 監測年長者及心臟損傷病患是否容量超載</td>
                        </tr>
                        <tr>
                            <td><b>口服直接凝血酶抑制劑</b><br>e.g., dabigatran (Pradaxa®)</td>
                            <td>• Idarucizumab (Praxbind®) 5g IV<br>• <b>或</b> 四因子PCC</td>
                            <td>若最後服藥時間在2小時內，可考慮使用活性碳。</td>
                        </tr>
                        <tr>
                            <td><b>靜脈注射直接凝血酶抑制劑</b><br>e.g., bivalirudin, argatroban</td>
                            <td>FFP 15 ml/kg (可重複)</td>
                            <td>• Idarucizumab (Praxbind®) 無效且未被核准<br>• 2-6小時內代謝<br>• Bivalirudin有透析移除的可能性</td>
                        </tr>
                        <tr>
                            <td><b>Xa因子抑制劑</b><br>rivaroxaban (Xarelto®), apixaban (Eliquis®)</td>
                            <td>• Andexanet alfa (Andexxa®)<br>• <b>或</b> 四因子PCC</td>
                            <td>• 劑量根據最後服藥時間調整<br>• 低劑量方案: 400 mg IV bolus, 接著 480 mg/2hr<br>• 高劑量方案: 800 mg bolus, 接著 960 mg/2hr<br>• 若最後服藥時間在2小時內，可考慮使用活性碳。</td>
                        </tr>
                        <tr>
                            <td><b>Xa因子抑制劑</b><br>edoxaban (Lixiana®, Savaysa®)</td>
                            <td>• (仿單外使用) Andexanet alfa (Andexxa®)<br>• <b>或</b> 四因子PCC</td>
                            <td>高劑量方案 (800 mg bolus, 接著 960 mg/2hr)</td>
                        </tr>
                        <tr>
                            <td><b>Xa因子抑制劑</b><br>fondaparinux (Arixtra®)</td>
                            <td>• (仿單外使用) Andexanet alfa (Andexxa®)<br>• <b>或</b> aPCC (FEIBA®) 20 u/kg 單次<br>• <b>或</b> rVIIa (NovoSeven®) 90 mcg/kg 單次 (若aPCC不可得)</td>
                            <td>Andexanet alfa的劑量尚未建立。</td>
                        </tr>
                        <tr>
                            <td><b>肝素 (Heparin) 連續輸注</b></td>
                            <td>Protamine sulfate</td>
                            <td>過去2小時內每100U肝素給予1 mg protamine，單次最高50 mg。</td>
                        </tr>
                         <tr>
                            <td><b>低分子量肝素 (LMWH)</b><br>e.g., enoxaparin (Lovenox®), dalteparin (Fragmin®), tinzaparin, nadroparin</td>
                            <td>Protamine sulfate</td>
                            <td>• <b>&lt;8小時內:</b> 每1mg LMWH給予1mg protamine<br>• <b>8-12小時:</b> 每1mg LMWH給予0.5mg protamine<br>• <b>>12小時:</b> 不需給藥</td>
                        </tr>
                    </tbody>
                </table>
            </div>

            <h3 id="clinical-assessment">📊 關鍵評估與判讀要點</h3>
            
            <div class="chart-box">
                <h4>📈 Shock Index (SI) = HR / SBP</h4>
                <p><strong>目的</strong>：早期偵測失血</p>
                <p><strong>快速判讀</strong>：</p>
                <ul>
                    <li>≥ 0.9 警訊</li>
                    <li>≥ 1 高死亡率</li>
                </ul>
                <p><strong>處置</strong>：立即啟動輸血與止血；持續監測至 < 0.8</p>
            </div>

            <div class="physiology-box">
                <h4>🧪 乳酸 / Base Deficit</h4>
                <p><strong>目的</strong>：細胞低灌流指標</p>
                <p><strong>臨界值</strong>：</p>
                <ul>
                    <li>Lactate > 2 mmol/L</li>
                    <li>Base Deficit < -2</li>
                </ul>
                <p><strong>監測</strong>：每 30-60 min 追蹤；趨勢下降代表復甦有效</p>
            </div>

            <div class="concept-box">
                <h4>🔄 Responder 分類</h4>
                <table>
                    <tr>
                        <th>類型</th>
                        <th>定義</th>
                        <th>處置方向</th>
                    </tr>
                    <tr>
                        <td>Responder</td>
                        <td>輸液後血壓穩定</td>
                        <td>持續監測</td>
                    </tr>
                    <tr>
                        <td>Transient</td>
                        <td>降速即惡化</td>
                        <td>持續輸血 + 手術諮詢</td>
                    </tr>
                    <tr>
                        <td>Non-responder</td>
                        <td>無改善</td>
                        <td>立即找致死性出血或非出血性休克源</td>
                    </tr>
                </table>
            </div>

            <h3 id="clinical-procedures">🔧 實務操作核心提示</h3>
            
            <div class="warning-box">
                <h4>💉 周邊粗短針優先</h4>
                <p>16 G × 5 cm 流速 > 18 G CVC</p>
                <p>確保兩條線、再考慮 IO</p>
                <p>💡 Poiseuille定律：流量 ∝ r⁴ / L</p>
            </div>

            <div class="dosage-box">
                <h4>🦴 Intraosseous (IO) 部位</h4>
                <ul>
                    <li>成人：鎖骨下端肱骨頭</li>
                    <li>兒童：脛骨近端</li>
                    <li>避免骨折遠端插入</li>
                    <li>流速等同 18 G 周邊針</li>
                </ul>
            </div>

            <div class="danger-box">
                <h4>🩹 Pelvic Binder 實務技巧</h4>
                <ol>
                    <li>折疊單層床單</li>
                    <li>沿大轉子環繞</li>
                    <li>前交叉回拉固定</li>
                    <li>塌陷外旋時將雙踝內收纏繃帶防再擴張</li>
                </ol>
            </div>

            <div class="physiology-box">
                <h4>🗣️ 口頭醫囑 / 交班縮寫 - SBAR-3C</h4>
                <ul>
                    <li><strong>S</strong>ituation：血壓 80/40，PRBC 第 2 U 進行中</li>
                    <li><strong>B</strong>ackground：刀傷 + FAST(+)，已 TXA 1 g</li>
                    <li><strong>A</strong>ssessment：Transient responder</li>
                    <li><strong>R</strong>ecommendation：開腹 hemostasis ASAP</li>
                    <li><strong>3C</strong>：Catheter Lines、Counts (unit given)、Complications 待觀察</li>
                </ul>
            </div>
        </div>

        <div id="charts" class="tab-content">
            <h2>📊 重要圖表整理</h2>
            
            <h3 id="chart-hemorrhage">📉 Table 6-2: 失血嚴重度分級表</h3>
            <div class="chart-box">
                <table id="hemorrhage-severity-table">
                    <thead>
                        <tr>
                            <th>PARAMETER</th>
                            <th>MINOR</th>
                            <th>MODERATE</th>
                            <th>MAJOR</th>
                            <th>MASSIVE</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Heart Rate (beats/min)</strong></td>
                            <td>Unchanged</td>
                            <td>Unchanged to Increased</td>
                            <td>Increased (&gt;100)</td>
                            <td>Markedly Increased (&gt;120)</td>
                        </tr>
                        <tr>
                            <td><strong>Systolic Pressure (mm Hg)</strong></td>
                            <td>Unchanged</td>
                            <td>Unchanged</td>
                            <td>Unchanged to Decreased</td>
                            <td>Markedly Decreased (&lt;90)</td>
                        </tr>
                        <tr>
                            <td><strong>Pulse Pressure</strong></td>
                            <td>Unchanged</td>
                            <td>Decreased</td>
                            <td>Decreased</td>
                            <td>Decreased</td>
                        </tr>
                        <tr>
                            <td><strong>Respiratory Rate</strong></td>
                            <td>Unchanged</td>
                            <td>Unchanged to Increased</td>
                            <td>Increased</td>
                            <td>Increased</td>
                        </tr>
                        <tr>
                            <td><strong>Level of Consciousness</strong></td>
                            <td>Unchanged</td>
                            <td>Unchanged</td>
                            <td>Decreased</td>
                            <td>Markedly Decreased</td>
                        </tr>
                        <tr>
                            <td><strong>Base Deficit (mEq/L)</strong></td>
                            <td>0 to -2</td>
                            <td>-2 to -6</td>
                            <td>-6 to -10</td>
                            <td>-10 and less</td>
                        </tr>
                        <tr>
                            <td><strong>Blood Products</strong></td>
                            <td>Unlikely</td>
                            <td>Possibly</td>
                            <td>Likely</td>
                            <td>Massive Transfusion Protocol</td>
                        </tr>
                        <tr>
                            <td><strong>Response to Resuscitation</strong></td>
                            <td>Rapid and Sustained</td>
                            <td>Fairly Rapid and Sustained</td>
                            <td>Transient</td>
                            <td>Minimal to None</td>
                        </tr>
                        <tr>
                            <td><strong>Operative Hemorrhage Control</strong></td>
                            <td>Unlikely</td>
                            <td>Possibly</td>
                            <td>Likely</td>
                            <td>Extremely Likely</td>
                        </tr>
                    </tbody>
                </table>
                <p>💡 <strong>記憶法</strong>：把四級想像成紅綠燈：Minor-綠、Moderate-黃、Major-橙、Massive-紅</p>
            </div>

            <h3 id="chart-bleeding">🩸 Figure 6-2: 五大失血位置示意圖</h3>
            <div class="physiology-box" id="bleeding-locations-diagram">
                <div class="diagram-container">
                    <div class="location-box external-hemorrhage">
                        <h5>E. 外部出血 ("The Floor")</h5>
                        <ul>
                            <li>頭皮撕裂傷 (Scalp laceration)</li>
                            <li>開放性骨折 (Open fracture)</li>
                        </ul>
                    </div>
                    <div class="location-box thoracic-cavity">
                        <h5>A. 胸腔 (Thoracic Cavity)</h5>
                        <ul>
                            <li>肺部撕裂傷 (Lung laceration)</li>
                            <li>血胸 (Hemo-thorax)</li>
                            <li>胸壁損傷 (Chest wall injury)</li>
                        </ul>
                    </div>
                    <div class="central-hub">
                        創傷出血五大位置<br>"One on the Floor and Four More"
                    </div>
                    <div class="location-box long-bone">
                        <h5>D. 長骨/軟組織腔室 (Long Bone/Soft Tissue Compartments)</h5>
                        <ul>
                            <li>閉鎖性長骨骨折 (Closed long bone fracture)</li>
                            <li>皮下組織/肌肉 (Subcutaneous tissue/muscle)</li>
                        </ul>
                    </div>
                    <div class="location-box retroperitoneal-space">
                        <h5>C. 後腹膜腔 (Retroperitoneal Space)</h5>
                        <ul>
                            <li>骨盆骨折 (Pelvic fracture)</li>
                            <li>腎臟等器官損傷 (Kidney/other organs)</li>
                            <li>腰椎損傷 (Lumbar spine injury)</li>
                        </ul>
                    </div>
                    <div class="location-box peritoneal-cavity">
                        <h5>B. 腹膜腔 (Peritoneal Cavity)</h5>
                        <ul>
                            <li>肝臟 (Liver)</li>
                            <li>脾臟 (Spleen)</li>
                            <li>腸道 (Intestines)</li>
                        </ul>
                    </div>
                </div>
                <p class="diagram-footnote">💡 <strong>應用</strong>：完成 xABCDE 後，立即以 "Floor → Chest → Abdomen → Pelvis/Retro → Long Bones" 次序檢查</p>
            </div>

            <h3 id="chart-pelvic">🦴 Figure 6-6: 骨盆容積變化圖</h3>
            <div class="warning-box">
                <h4>骨盆骨折與綁帶效果</h4>
                <ol>
                    <li><strong>A. 正常骨盆</strong>：紅色區域 = 100% 容積</li>
                    <li><strong>B. "Open-book" 骨折</strong>：恥骨聯合裂開 → 紅色區域擴大 (↑ 40%)</li>
                    <li><strong>C. 綁單層床單於 Greater Trochanters</strong>：紅色區域恢復近正常，骨盆容積↓</li>
                </ol>
                <p>💡 <strong>記憶法</strong>：想像"打包行李"：骨盆像打開的行李箱 (open-book)；綁帶=拉鍊；✨拉回大轉子→把血「塞不進去」</p>
            </div>

            <h3 id="chart-flow">💉 Figure 6-9: 導管流速比較表</h3>
            <div class="dosage-box">
                <h4>Poiseuille's Law: Flow ∝ r⁴ / L</h4>
                <table>
                    <tr>
                        <th>導管規格</th>
                        <th>流速 (mL/min)</th>
                        <th>臨床應用</th>
                    </tr>
                    <tr>
                        <td>14 G × 5 cm</td>
                        <td>≈ 360</td>
                        <td>大量輸血首選</td>
                    </tr>
                    <tr>
                        <td>16 G × 5 cm</td>
                        <td>≈ 215</td>
                        <td>標準急救選擇</td>
                    </tr>
                    <tr>
                        <td>18 G × 30 cm (CVC)</td>
                        <td>< 100</td>
                        <td>藥物給予，非快速輸血</td>
                    </tr>
                </table>
                <p>💡 <strong>口訣</strong>：「短粗飆，長細慢」</p>
            </div>

            <div class="concept-box">
                <h4>🔍 Table 6-3: 骨盆骨折臨床因子</h4>
                <table>
                    <tr>
                        <th>類別</th>
                        <th>重點項目</th>
                    </tr>
                    <tr>
                        <td><strong>Mechanism</strong></td>
                        <td>車禍、墜落、高處跌落、馬匹/動物跌落、壓砸、單車撞</td>
                    </tr>
                    <tr>
                        <td><strong>Symptoms</strong></td>
                        <td>骨盆痛、下腹痛、臀/髖痛、下肢放射痛、下背痛</td>
                    </tr>
                    <tr>
                        <td><strong>Signs</strong></td>
                        <td>低血壓+頻脈、骨盆壓痛、下腹壓痛、髖關節痛、雙下肢外旋、骶尾壓痛、恥骨聯合擴大、鼠蹊/會陰瘀青、尿道口/陰道出血</td>
                    </tr>
                </table>
                <p>💡 <strong>記憶法</strong>：M-S-S（Mechanism-Symptoms-Signs）</p>
            </div>
            
            <div class="concept-box">
                <h3 id="chart-perfusion-signs">📊 Table 6-4: 休克之臨床異常與灌流改善跡象</h3>
                <table>
                    <thead>
                        <tr>
                            <th>系統</th>
                            <th>休克 (Shock)</th>
                            <th>灌流改善 (Improved Perfusion)</th>
                            <th>限制 (Limitations)</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>中樞神經 (CNS)</strong></td>
                            <td>早期躁動<br>晚期嗜睡</td>
                            <td>意識狀態改善</td>
                            <td>可能被伴隨的TBI、中毒、藥物混淆<br>插管病人無法評估<br>觀察者間差異</td>
                        </tr>
                        <tr>
                            <td><strong>皮膚 (Skin)</strong></td>
                            <td>冰冷、濕黏<br>微血管填充時間延長 (&gt;2秒)</td>
                            <td>體溫改善<br>微血管填充時間改善</td>
                            <td>主觀性<br>受外部溫度影響</td>
                        </tr>
                        <tr>
                            <td><strong>腎臟 (Renal)</strong></td>
                            <td>腎前性衰竭<br>寡尿/無尿</td>
                            <td>尿量足夠*</td>
                            <td>評估需數小時<br>無即時指標<br>慢性腎病影響<br>利尿劑/高血糖影響</td>
                        </tr>
                        <tr>
                            <td><strong>血行動力學 (Hemodynamic)</strong></td>
                            <td>心搏過速*<br>觸診脈搏微弱<br>低血壓*</td>
                            <td>趨於正常化<br>可觸及之脈搏強度改善<br>血壓正常化</td>
                            <td>非侵入性測量可能不準<br>數值可能造成誤導性的安心<br>宏觀穩定不代表細胞層級灌流正常<br>受藥物及先前病史影響</td>
                        </tr>
                    </tbody>
                </table>
                <p style="font-size: 0.8em;">* 臨床數值需根據年齡校正評估。TBI: 創傷性腦損傷 (Traumatic brain injury)。</p>
            </div>

            <div class="warning-box">
                <h3 id="chart-nonresponse-reasons">📋 Table 6-5: 對復甦無反應之原因</h3>
                <table style="vertical-align: middle;">
                    <thead style="text-align: center;">
                        <tr>
                            <th style="width: 25%;">原因類別</th>
                            <th>主要病因</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td rowspan="3" style="font-weight: bold; text-align: center; vertical-align: middle;">持續性出血<br>(Continuing Hemorrhage)</td>
                            <td><b>可壓迫性出血處理不當：</b><br>未識別的損傷、傷口填塞不足、骨盆壓迫裝置或止血帶使用不當</td>
                        </tr>
                        <tr>
                            <td><b>不可壓迫性出血：</b><br>腹內、骨盆動脈、穿透性交界區血管損傷</td>
                        </tr>
                        <tr>
                            <td><b>凝血功能病變：</b><br>傷前用藥、血液製品輸注失衡、過度纖維蛋白溶解</td>
                        </tr>
                        <tr>
                            <td rowspan="4" style="font-weight: bold; text-align: center; vertical-align: middle;">復甦不全<br>(Inadequate Resuscitation)</td>
                            <td>軟組織及肌肉內挫傷與撕裂傷</td>
                        </tr>
                        <tr>
                            <td>骨折造成的失血</td>
                        </tr>
                         <tr>
                            <td>合併燒燙傷</td>
                        </tr>
                        <tr>
                            <td>到院前未被識別的失血</td>
                        </tr>
                         <tr>
                            <td rowspan="5" style="font-weight: bold; text-align: center; vertical-align: middle;">非出血性休克<br>(Non-Hemorrhagic Shock)</td>
                            <td><b>阻塞性休克：</b>張力性氣胸、張力性血胸、心包填塞</td>
                        </tr>
                         <tr>
                            <td><b>神經性休克</b></td>
                        </tr>
                        <tr>
                            <td><b>心因性休克：</b>心臟鈍傷、急性心肌梗塞</td>
                        </tr>
                         <tr>
                            <td><b>敗血性休克：</b>腹內敗血症、肺炎、泌尿道敗血症</td>
                        </tr>
                        <tr>
                            <td><b>內分泌與代謝性休克：</b>糖尿病酮酸中毒、腎上腺功能不全</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            
            <h3 id="chart-variable-response">👥 Table 6-6: 不同族群對復甦反應的特殊考量</h3>
            <div class="physiology-box">
                <h4>🤰 孕婦 (Pregnant)</h4>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 40%;">影響因子</th>
                            <th>臨床提示/註解</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td>生理性血容量過多 (Physiologic hypervolemia)</td>
                            <td>即使脈搏和血壓正常，仍可能存在胎盤灌流不足。</td>
                        </tr>
                        <tr>
                            <td>生理性正常偏低之收縮壓 (Physiologic lower normal systolic pressure)</td>
                            <td>可能在沒有休克臨床症狀的情況下就已大量失血。</td>
                        </tr>
                        <tr>
                            <td>妊娠子宮壓迫下腔靜脈 (Vena cava compression by gravid uterus)</td>
                            <td>未能手動將子宮推向左側，可能解釋為何復甦反應不佳。</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="physiology-box">
                <h4>👵 年長者 (Older Adult)</h4>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 40%;">影響因子</th>
                            <th>臨床提示/註解</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td>交感神經受體減少、合併使用Beta/鈣離子通道阻斷劑、心律調節器</td>
                            <td>心搏過速的代償能力減弱；無法有效增加心輸出量。</td>
                        </tr>
                        <tr>
                            <td>使用利尿劑導致血容量縮減 (Diuretics with contracted blood volume)</td>
                            <td>即使是輕度失血，也可能導致更嚴重的休克和器官缺血。</td>
                        </tr>
                        <tr>
                            <td>動脈粥樣硬化、傷前心臟代償力下降 (Atherosclerotic disease / Preinjury reduced capacity)</td>
                            <td>因生理需求增加及圍手術期心肌梗塞風險，心臟失償風險上升。</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="physiology-box">
                <h4>👶 孩童 (Child)</h4>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 40%;">影響因子</th>
                            <th>臨床提示/註解</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td>高交感神經張力、高效率的生理代償反應</td>
                            <td>能維持生命徵象穩定，直到因快速失代償而休克；心搏過緩是比心搏過速更不祥的徵兆。</td>
                        </tr>
                        <tr>
                            <td>絕對血容量小 (Small absolute blood volume)</td>
                            <td>因未能意識到「失血比例」而非「失血量」，可能導致復甦反應不佳。</td>
                        </tr>
                        <tr>
                            <td>可移動且順應性高的組織 (Mobile and compliant tissues)</td>
                            <td>胃擴張可能導致低血壓；可能快速發展成張力性氣胸。</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="physiology-box">
                <h4>🏃 運動員 (Athlete)</h4>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 40%;">影響因子</th>
                            <th>臨床提示/註解</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td>傷前靜止心率較低 (Lower preinjury pulse rate)</td>
                            <td>每單位休克程度的心搏過速反應較輕微。</td>
                        </tr>
                        <tr>
                            <td>生理代償能力較強 (Increased physiologic capacity for compensation)</td>
                            <td>因臨床症狀輕微，有低估休克嚴重程度的風險。</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div id="others" class="tab-content">
            <h2>📌 其他重要重點</h2>
            
            <h3 id="other-nonhemorrhagic">🚫 非出血性休克3大類（Table 6-1）</h3>
            <div class="danger-box">
                <ul>
                    <li><strong>Obstructive</strong>：Tension pneumothorax、Cardiac tamponade</li>
                    <li><strong>Cardiogenic</strong>：Blunt cardiac injury、AMI</li>
                    <li><strong>Distributive</strong>：Neurogenic、Septic、Anaphylactic</li>
                </ul>
                <p>→ 判別後立即啟動病因導向處置（減壓、經皮/開胸引流、強心或升壓）</p>
            </div>

            <h3 id="other-population">👥 不同族群對復甦反應差異（Table 6-6）</h3>
            <table>
                <tr>
                    <th>族群</th>
                    <th>影響因子</th>
                    <th>臨床提示</th>
                </tr>
                <tr>
                    <td><strong>孕婦</strong></td>
                    <td>下腔靜脈壓迫、血容量↑</td>
                    <td>正常或偏低 SBP 不能排除休克；先左移子宮再評估</td>
                </tr>
                <tr>
                    <td><strong>高齡</strong></td>
                    <td>β/鈣離子阻斷、動脈硬化</td>
                    <td>HR 不一定上升；輕度失血即心肌缺氧</td>
                </tr>
                <tr>
                    <td><strong>兒童</strong></td>
                    <td>高交感與儲備量</td>
                    <td>末期才血壓下降；Bradycardia 是危險信號</td>
                </tr>
            </table>

            <h3 id="other-tca">💔 Traumatic Cardiac Arrest（TCA）續救或終止（Table 6-8）</h3>
            <div class="warning-box">
                <h4>可視為「有生命跡象」：</h4>
                <ul>
                    <li>瞳孔反射</li>
                    <li>任何自主呼吸</li>
                    <li>可觸脈搏或量得血壓</li>
                    <li>肢體動作</li>
                    <li>心電圖有電活動</li>
                </ul>
                
                <h4>停止 CPR 時機：</h4>
                <ul>
                    <li>鈍傷 > 10 min</li>
                    <li>穿刺傷 > 15 min 仍無 ROSC</li>
                    <li>PoCUS 無心臟運動且僅電活動</li>
                </ul>
            </div>

            <div class="physiology-box">
                <h4>❄️ 體溫、酸鹼、凝血三重打擊</h4>
                <ul>
                    <li>低溫（< 35 °C）</li>
                    <li>酸中毒（pH < 7.2）</li>
                    <li>凝血功能異常形成惡性循環</li>
                </ul>
                <p><strong>防治重點</strong>：39 °C 血品／輸液加溫、及早糾正酸血、使用平衡晶體降低氯酸中毒</p>
            </div>

            <div class="concept-box">
                <h4>🔍 FAST 與 DPL 快速比較</h4>
                <table>
                    <tr>
                        <th>工具</th>
                        <th>優點</th>
                        <th>侷限</th>
                    </tr>
                    <tr>
                        <td><strong>FAST / eFAST</strong></td>
                        <td>非侵入、可重複、胸腹同時掃</td>
                        <td>早期少量血易漏；操作者依賴</td>
                    </tr>
                    <tr>
                        <td><strong>DPL</strong></td>
                        <td>靈敏度高，可在無影像設備時用</td>
                        <td>侵入性；不區分泌液來源，可能干擾後續腹腔評估</td>
                    </tr>
                </table>
            </div>

            <div class="danger-box">
                <h4>🚁 資源不足時的轉診與持續復甦</h4>
                <ul>
                    <li>一旦判定需手術/血管介入而院內超過能力，邊復甦邊啟動轉診</li>
                    <li>轉運前明確交班：現有 IV/IO 條數、剩餘血品量、出血控制方式及備案</li>
                </ul>
            </div>

            <div class="concept-box">
                <h4>🎯 本章核心學習目標摘要</h4>
                <ol>
                    <li>迅速識別各型休克並在 xABCDE 流程中同步處置</li>
                    <li>依「病因-導向」調整輸液與控制出血策略</li>
                    <li>持續評估、動態修正治療並隨時考慮資源與轉診選項</li>
                </ol>
            </div>
        </div>
    </div>

    <script>
        // 分頁切換功能
        function showTab(tabName) {
            const tabs = document.querySelectorAll('.tab-content');
            const buttons = document.querySelectorAll('.tab-button');
            
            tabs.forEach(tab => {
                tab.classList.remove('active');
            });
            
            buttons.forEach(button => {
                button.classList.remove('active');
            });
            
            document.getElementById(tabName).classList.add('active');
            event.target.classList.add('active');
        }

        // 問答收合功能
        function toggleAnswer(element) {
            const answer = element.nextElementSibling;
            const toggle = element.querySelector('.qa-toggle');
            
            answer.classList.toggle('open');
            toggle.classList.toggle('open');
        }

        // 下載PDF功能
        function downloadPDF() {
            window.print();
        }

        // 返回頂部功能
        function scrollToTop() {
            window.scrollTo({
                top: 0,
                behavior: 'smooth'
            });
        }

        // 顯示/隱藏返回頂部按鈕
        window.onscroll = function() {
            const backToTopBtn = document.getElementById('back-to-top');
            const progressBar = document.getElementById('progress-bar');
            
            // 返回頂部按鈕
            if (document.body.scrollTop > 300 || document.documentElement.scrollTop > 300) {
                backToTopBtn.style.display = 'flex';
            } else {
                backToTopBtn.style.display = 'none';
            }
            
            // 進度條
            const winScroll = document.body.scrollTop || document.documentElement.scrollTop;
            const height = document.documentElement.scrollHeight - document.documentElement.clientHeight;
            const scrolled = (winScroll / height) * 100;
            progressBar.style.width = scrolled + '%';
        };

        // 平滑滾動到錨點
        document.querySelectorAll('a[href^="#"]').forEach(anchor => {
            anchor.addEventListener('click', function (e) {
                e.preventDefault();
                const target = document.querySelector(this.getAttribute('href'));
                if (target) {
                    target.scrollIntoView({
                        behavior: 'smooth',
                        block: 'start'
                    });
                }
            });
        });
    </script>
</body>
</html>